Commonwealth Consolidated Regulations

[Index] [Table] [Search] [Search this Regulation] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

CIVIL AVIATION SAFETY REGULATIONS 1998 - REG 99.175

Notices of initial drug test

Notice to donor

             (1)  The notice given to the donor under paragraph 99.170(5)(a) must contain the following:

                     (a)  the donor's name, date of birth, gender, residential address and telephone number, and an indication of whether those details were provided by the donor or the donor's DAMP organisation (if any) or a DAMP contractor;

                     (b)  the date and time that the donor was asked by the approved tester to stop performing or being available to perform SSAAs for the purposes of giving a body sample for a drug test;

                     (c)  the applicable SSAA that the donor was performing or available to perform at the time the donor was tested;

                     (d)  the date, time and location of the place that an initial drug test was conducted on the donor's body sample;

                     (e)  the test result for the initial drug test;

                      (f)  the initials of the tester and his or her allocated number;

                     (g)  the details of any photographic identification provided by the donor;

                     (h)  the make, model and serial number of the approved drug testing device used to conduct the initial drug test;

                      (i)  the sample identifier allocated to the body sample taken for a confirmatory drug test by the approved tester (see paragraph 99.180(1)(a));

                      (j)  a certification by the tester about whether the body sample has been taken and tested in accordance with the requirements of the Regulations and any applicable legislative instrument made by CASA under regulation 99.140;

                     (k)  a certification by the tester about whether the device has been stored, tested, maintained and operated in accordance with the legislative instrument made by CASA under subregulation 99.145(2).

Note:          Subregulation 99.180(7) may also require the notice to contain certain things.

Notice to approved laboratory

             (3)  For paragraph 99.170(5)(b), the notice must contain the following:

                     (a)  the sample identifier allocated to the body sample by the approved tester;

                     (b)  the date time that the body sample was given;

                     (c)  the results of the initial drug test;

                     (d)  the list of testable drugs that the tester wants the approved laboratory to test for in the confirmatory drug test;

                     (e)  the name of the approved tester.



AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback